Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study
- 1 July 2014
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 121 (1) , 114-122
Abstract
Object: To date, experience of globus pallidus internus (GPi) deep brain stimulation (DBS) in the treatment of Huntington's disease (HD) has been limited to a small number of case reports. The aim of this study was to analyze long-term motor outcome of a cohort of HD patients treated with GPi DBS. Methods: Seven patients with pharmacologically resistant chorea and functional impairment were included in a prospective open-label study from 2008 to 2011. The main outcome measure was the motor section of the Unified Huntington's Disease Rating Scale. The primary end point was reduction of chorea. Results: Patients underwent MRI-guided bilateral GPi implantation. The median duration of follow-up was 3 years. A significant reduction of chorea was observed in all patients, with sustained therapeutic effect; the mean improvement on the chorea subscore was 58.34% at the 12-month follow-up visit (p = 0.018) and 59.8% at the 3-year visit (p = 0.040). Bradykinesia and dystonia showed a nonsignificant trend toward progressive worsening related to disease evolution and partly to DBS. The frequency of stimulation was 130 Hz for all patients. DBS-induced bradykinesia was managed by pulse-width reduction or bipolar settings. Levodopa mildly improved bradykinesia in 4 patients. Regular off-stimulation tests confirmed a persistent therapeutic effect of DBS on chorea. Conclusions: GPi DBS may provide sustained chorea improvement in selected HD patients with pharmacologically resistant chorea, with transient benefit in physical aspects of quality of life before progression of behavioral and cognitive disorders. DBS therapy did not improve dystonia or bradykinesia. Further studies including quality of life measures are needed to evaluate the impact of DBS in the long-term outcome of HD.Keywords
This publication has 43 references indexed in Scilit:
- Differential and Better Response to Deep Brain Stimulation of Chorea Compared to Dystonia in Huntington’s DiseaseStereotactic and Functional Neurosurgery, 2013
- An evidence-based approach in the treatment of Huntington’s diseaseParkinsonism & Related Disorders, 2012
- Huntington’s disease from the patient, caregiver and physician’s perspectives: three sides of the same coin?Journal of Neural Transmission, 2012
- Health-related quality of life in Huntington’s disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington’s disease health-related quality of life questionnaire (HDQoL)Journal of Neurology, 2012
- The Huntington's Disease health‐related Quality of Life questionnaire (HDQoL): a disease‐specific measure of health‐related quality of lifeClinical Genetics, 2011
- Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspectiveClinical Genetics, 2011
- Does reduced [123I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?Clinical Neurology and Neurosurgery, 2010
- Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD InvestigatorsBMC Neurology, 2009
- Patterns of reoccurrence of segmental dystonia after discontinuation of deep brain stimulationJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Levodopa responsive parkinsonism in an adult with Huntington's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1998